VEGFA and non-small cell lung carcinoma: Compound 151 has also been found to strongly inhibit angiogenesis and angiogenic mimicry in vitro and ex vivo, specifically by decreasing VEGF-A levels and inhibiting the VEGF-A/VEGFR2 signalling pathway in non-small-cell lung cancer (Lin et al. 2023) (Figure 7).